UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 269

Sortiert nach

Acquired mutations in TET2 are common in myelodysplastic syndromes

Nature genetics, 2009-07, Vol.41 (7), p.838-842

2009

Link zum Volltext

Verfügbarkeit prüfen

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Haematologica (Roma), 2012-03, Vol.97 (3), p.393-401

2012

Link zum Volltext

Verfügbarkeit prüfen

Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

Journal of clinical oncology, 2008-10, Vol.26 (29), p.4791-4797

2008

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Gastroenterology (New York, N.Y. 1943), 2005-02, Vol.128 (2), p.270-279

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

Genes chromosomes & cancer, 2002-08, Vol.34 (4), p.354-362

2002

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site

Modern pathology, 2004-08, Vol.17 (8), p.889-894

2004

Link zum Volltext

Verfügbarkeit prüfen

ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor

Genes chromosomes & cancer, 2003-10, Vol.38 (2), p.187-190

2003

Link zum Volltext

Verfügbarkeit prüfen

The Leukemic Fusion Gene AML1-MDS1-EVI1 Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (36), p.13312-13317

2004

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances

Blood, 2001-03, Vol.97 (6), p.1845-1853

2001

Link zum Volltext

Verfügbarkeit prüfen

Histologic Localization of PLAG1 (Pleomorphic Adenoma Gene 1) in Pleomorphic Adenoma of the Salivary Gland: Cytogenetic Evidence of Common Origin of Phenotypically Diverse Cells

Laboratory investigation, 2001-09, Vol.81 (9), p.1289-1297

2001

Link zum Volltext

Verfügbarkeit prüfen

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

European journal of cancer (1990), 2006-05, Vol.42 (8), p.1093-1103

2006

Link zum Volltext

Verfügbarkeit prüfen

The Cryptic inv(2)(p23q35) Defines a New Molecular Genetic Subtype of ALK-Positive Anaplastic Large-Cell Lymphoma

Blood, 1998-10, Vol.92 (8), p.2688-2695

1998

Link zum Volltext

Verfügbarkeit prüfen

Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop

Genes chromosomes & cancer, 2002-04, Vol.33 (4), p.401-412

2002

Link zum Volltext

Verfügbarkeit prüfen

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

The Journal of experimental medicine, 2008-10, Vol.205 (11), p.2499-2506

2008

Link zum Volltext

Verfügbarkeit prüfen

ABL1 rearrangements in T-Cell acute lymphoblastic leukemia

Genes chromosomes & cancer, 2010-04, Vol.49 (4), p.299-308

2010

Link zum Volltext

Verfügbarkeit prüfen

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Nature genetics, 2004-10, Vol.36 (10), p.1084-1089

2004

Link zum Volltext

Verfügbarkeit prüfen

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia

Annals of hematology, 2020-07, Vol.99 (7), p.1551-1560

2020

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity

The Journal of pathology, 2004-04, Vol.202 (4), p.430-438

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(245)

Publikationsform

Artikel
(262)
Reviews
(3)
Berichte
(2)
Webseiten
(2)

Sprache

Englisch
(269)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Humans
(181)
Science & Technology
(168)
Life Sciences & Biomedicine
(164)
Male
(108)
Biological And Medical Sciences
(107)
Female
(101)
Medical Sciences
(101)
Middle Aged
(86)
Oncology
(86)
Adult
(76)
Aged
(68)
Hematologic And Hematopoietic Diseases
(66)
Hematology
(66)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(65)
Genetics & Heredity
(62)
In Situ Hybridization, Fluorescence
(52)
Translocation, Genetic
(50)
Karyotyping
(47)
Chromosome Aberrations
(39)
Adolescent
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acquired mutations in TET2 are common in myelodysplastic syndromes

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene

Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site

ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor

The Leukemic Fusion Gene AML1-MDS1-EVI1 Suppresses CEBPA in Acute Myeloid Leukemia by Activation of Calreticulin

Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances

Histologic Localization of PLAG1 (Pleomorphic Adenoma Gene 1) in Pleomorphic Adenoma of the Salivary Gland: Cytogenetic Evidence of Common Origin of Phenotypically Diverse Cells

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

The Cryptic inv(2)(p23q35) Defines a New Molecular Genetic Subtype of ALK-Positive Anaplastic Large-Cell Lymphoma

Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an International Workshop

Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

ABL1 rearrangements in T-Cell acute lymphoblastic leukemia

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia

Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial

Suchergebnisse filtern